Here we provide evidence that a novel RNF5 activator, Analog-1, exerted a potent anti-tumor effect in in vitro and in vivo NB and melanoma models through down-regulation of cell metabolism, inhibition of proliferation and induction of apoptosis. The gene discussed is RNF5; the disease is neuroblastoma.